NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,247,338 | +180.9% | 22,063 | +125.5% | 0.80% | +147.7% |
| Q3 2021 | $800,000 | -11.9% | 9,782 | -1.7% | 0.32% | -17.1% |
| Q2 2021 | $908,000 | +9.1% | 9,952 | +2.3% | 0.39% | -4.2% |
| Q1 2021 | $832,000 | -5.2% | 9,730 | +4.7% | 0.41% | -15.8% |
| Q4 2020 | $878,000 | +14.5% | 9,293 | +5.4% | 0.49% | +2.1% |
| Q3 2020 | $767,000 | +1.2% | 8,816 | +1.6% | 0.48% | -9.0% |
| Q2 2020 | $758,000 | +8.3% | 8,674 | +2.2% | 0.52% | -10.4% |
| Q1 2020 | $700,000 | -57.6% | 8,487 | -50.5% | 0.58% | -54.2% |
| Q1 2019 | $1,649,000 | +13.9% | 17,150 | +1.6% | 1.28% | -3.3% |
| Q4 2018 | $1,448,000 | -2.3% | 16,873 | -1.9% | 1.32% | +18.3% |
| Q3 2018 | $1,482,000 | +12.9% | 17,206 | -1.0% | 1.12% | +4.2% |
| Q2 2018 | $1,313,000 | -13.5% | 17,380 | -7.4% | 1.07% | -16.4% |
| Q1 2018 | $1,518,000 | -2.3% | 18,774 | +1.4% | 1.28% | -12.0% |
| Q4 2017 | $1,554,000 | – | 18,511 | – | 1.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newman Dignan & Sheerar, Inc. | 3,739 | $353,074,000 | 56.77% |
| Susquehanna International Securities, Ltd. | 118,837 | $11,222,000 | 8.15% |
| MANAGED ASSET PORTFOLIOS, LLC | 336,762 | $31,800,000 | 5.59% |
| Martin Investment Management, LLC | 169,019 | $15,960,000 | 5.10% |
| SCHARF INVESTMENTS, LLC | 1,197,539 | $113,083,000 | 4.26% |
| GARLAND CAPITAL MANAGEMENT INC | 50,705 | $4,788,000 | 4.06% |
| Mawer Investment Management Ltd. | 6,625,594 | $625,655,000 | 3.69% |
| SPHERA FUNDS MANAGEMENT LTD. | 429,000 | $40,510,000 | 3.60% |
| First Fiduciary Investment Counsel, Inc. | 196,693 | $18,574,000 | 3.48% |
| PROFESSIONAL ADVISORY SERVICES INC | 227,971 | $21,527,000 | 3.46% |